Adverse Ocular Effects of Systemic Medications

MB Green, JS Duker - Life, 2023 - mdpi.com
While ocular complications of systemic medications are uncommon, it is important to
recognize that vision-threatening toxicities can occur. This review details the vision …

[PDF][PDF] 半量睫状体光凝术对青光眼患者生活质量及血清Endothelin-1 水平的影响

蒋晨, 万新娟, 谢小东, 刘琪, 丁琳 - Age (years), 2022 - biomed.cnjournals.com
摘要目的: 探究半量睫状体光凝术对青光眼患者生活质量及血清内皮素(ET-1) 水平的影响. 方法:
选择2018 年4 月至2021 年4 月于我院接受治疗的80 例(80 眼) 青光眼患者为研究对象 …

Internistische Erkrankungen und Zusammenhang mit dem primären Offenwinkelglaukom

AM Voigt, S Grabitz, EM Hoffmann… - Klinische …, 2024 - thieme-connect.com
Primary open-angle glaucoma is a neurodegenerative disease with progressive chronic
optic neuropathy and corresponding visual field defects. In this literature review, we discuss …

[PDF][PDF] 托拉塞米致视野缺失

郝杰, 原小童, 李玉旺, 彭芳辰, 李元平 - 药物不良反应杂志, 2022 - cadrj.com
1 例53 岁男性糖尿病肾病Ⅳ 期患者因双下肢水肿接受托拉塞米40 mg/d 入小壶静脉滴注.
用药第3 天因利尿效果欠佳遵医嘱将托拉塞米剂量增至80 mg/d. 8 h 后, 患者出现双眼两侧视物 …

The effect of Calcium channel blocker in the Betamethasone-induced Glaucoma model in rabbits

WK Abdulsahib, SJ Abood - Journal of Advanced Pharmacy Education and …, 2021 - japer.in
Abstract To Evaluate the Ocular-hypotensive Effect of Levamlodipine in the Betamethasone-
induced Glaucoma Model in the Rabbits. Ocular-hypertension was made by weekly …

Medication Induced Glaucoma

M Mansoor, I Nwokeji, LM Provencher - Current Ophthalmology Reports, 2023 - Springer
Purpose To discuss current definitions, pathophysiology, diagnosis, and management of
medication-induced glaucoma. Recent Findings Treatment of steroid-induced glaucoma …

[PDF][PDF] Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy. Polymers 2022, 14, 2359

KA Akulo, T Adali, MTG Moyo, T Bodamyali - 2022 - academia.edu
Glaucoma is extensively treated with topical eye drops containing drugs. However, the
retention time of the loaded drugs and the in vivo bioavailability of the drugs are highly …

Клинические особенности развития и прогрессирования первичной открытоугольной глаукомы у пациентов с отягощенным семейным анамнезом

ИА Булах, ПЧ Завадский, СН Ланин… - Национальный …, 2023 - glaucomajournal.ru
Аннотация ЦЕЛЬ. Определение клинико-эпидемиологических особенностей развития
прогрессирования первичной открытоугольной глаукомы (ПОУГ) у пациентов с …

Corticotrophins, corticosteroids, and prostaglandins

E Samuel, D Fakharzadeh, B Prophete, SD Ray… - Side Effects of Drugs …, 2021 - Elsevier
In this chapter, we have reviewed side effects reported for corticotrphins, systemic
glucocorticoids, and prostaglandin analogues from January 2020 to June 2021. We used …

Neuroprotektive Wirkungen von Antidiabetika in der Therapie von Patienten mit Diabetes und Glaukom oder hohem Glaukomrisiko

B Weisser, C Erb - Klinische Monatsblätter für Augenheilkunde, 2024 - thieme-connect.com
There is an association between glaucoma and several risk factors and metabolic diseases,
such as type 2 diabetes mellitus. Diabetes mellitus leads to neurodegenerative changes …